Idiopathic pulmonary fibrosis (IPF) is a progressive and fibrosing lung disease with a poor
prognosis. Between 60% and 70% of IPF patients die of IPF; the remaining causes of death …

Objective. The aim of this study is to evaluate the efficacy and safety of pulmonary
rehabilitation (PR) in patients with idiopathic pulmonary fibrosis (IPF). Methods. Embase …

Dyspnea and exercise limitation are among the most common symptoms experienced by
patients with various chronic lung diseases and are linked to poor quality of life. Our …

Abundant evidence supports the use of pulmonary rehabilitation as a treatment for stable
and exacerbated chronic obstructive pulmonary disease. Several questions around the …

Background The adherence to and clinical efficacy of pulmonary rehabilitation in idiopathic
pulmonary fibrosis (IPF), particularly in comparison to people with chronic obstructive …

Background Exercise training is important in the management of adults with chronic
pulmonary conditions. However, achieving high intensity exercise may be challenging for …

Interstitial lung disease (ILD) is one of the most serious pulmonary complications of
connective tissue diseases (CTDs) and it is characterized by a deep impact on morbidity and …

Objective To summarise all meta-analyses of randomised controlled trials that have
evaluated the effects of exercise therapy on functional capacity in patients with chronic …

Systemic sclerosis (SSc) is a multi-organ autoimmune disease with complex interactions
between immune-mediated inflammatory processes and vascular pathology leading to small …

Similarly to idiopathic pulmonary fibrosis (IPF), other interstitial lung diseases can develop
progressive pulmonary fibrosis (PPF) characterized by declining lung function, a poor …